Trial NCT02108951

View at ClinicalTrials.gov 
Org. Study IDs: CAMN107AAU04

Last trial update was posted on 2017-10-27

MeSH Interventions

Nilotinib

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid

Other Conditions

Philidelphia Positive Chronic Myeloid Leukaemia

Stopping Reasons

Study was terminated because of slow recruitment

Limitations And Caveats

The study was planned to enroll 130 patients. Study got terminated with 20 patients because of slow recruitment. Therefore, due to small sample size, the results cannot be considered clinical significant.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID